These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 27576453
1. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Mustafa S, Devi VK, Pai RS. Drug Deliv Transl Res; 2017 Feb; 7(1):27-36. PubMed ID: 27576453 [Abstract] [Full Text] [Related]
2. Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan. Mustafa S, Devi VK, Pai RS. J Drug Deliv; 2017 Feb; 2017():1253294. PubMed ID: 28352475 [Abstract] [Full Text] [Related]
3. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, Zhou H, Xu F. Biomaterials; 2009 Apr; 30(12):2340-8. PubMed ID: 19150737 [Abstract] [Full Text] [Related]
4. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase. Sheng Y, He H, Zou H. Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098 [Abstract] [Full Text] [Related]
5. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y. J Control Release; 2017 Dec 28; 268():407-415. PubMed ID: 29111150 [Abstract] [Full Text] [Related]
6. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S, Sahoo SK. Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969 [Abstract] [Full Text] [Related]
7. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P, Haddadi A. Int J Nanomedicine; 2017 Nov 30; 12():935-947. PubMed ID: 28184163 [Abstract] [Full Text] [Related]
8. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Wang G, Chen Y, Wang P, Wang Y, Hong H, Li Y, Qian J, Yuan Y, Yu B, Liu C. Acta Biomater; 2016 Jan 30; 29():248-260. PubMed ID: 26476340 [Abstract] [Full Text] [Related]
9. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z, Huang H, Huang L, Du L, Sun Y, Duan Y. Int J Mol Sci; 2017 Apr 13; 18(4):. PubMed ID: 28406431 [Abstract] [Full Text] [Related]
10. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S, Nandhakumar P, Pandiyan V, Webster TJ, Balasubramanian S. Int J Nanomedicine; 2015 Apr 13; 10():2207-18. PubMed ID: 25848248 [Abstract] [Full Text] [Related]
11. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y, Xie XY, Mei XG. Drug Deliv; 2016 Apr 13; 23(3):787-93. PubMed ID: 24870204 [Abstract] [Full Text] [Related]
12. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882 [Abstract] [Full Text] [Related]
13. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F. J Control Release; 2012 Jan 10; 157(1):149-59. PubMed ID: 21864595 [Abstract] [Full Text] [Related]
14. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells]. Wen Z, Li G, Lin DH, Wang JT, Qin LF, Guo GP. Yao Xue Xue Bao; 2013 Dec 10; 48(12):1829-35. PubMed ID: 24689242 [Abstract] [Full Text] [Related]
15. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Navarro SM, Darensbourg C, Cross L, Stout R, Coulon D, Astete CE, Morgan T, Sabliov CM. Ther Deliv; 2014 Nov 10; 5(11):1191-201. PubMed ID: 25491670 [Abstract] [Full Text] [Related]
16. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. Lin TsT, Gao DY, Liu YC, Sung YC, Wan D, Liu JY, Chiang T, Wang L, Chen Y. J Control Release; 2016 Jan 10; 221():62-70. PubMed ID: 26551344 [Abstract] [Full Text] [Related]
17. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS, Mei L, Anitha P, Gan CW, Zhou W. Biomaterials; 2009 Jul 10; 30(19):3297-306. PubMed ID: 19299012 [Abstract] [Full Text] [Related]
18. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. Han X, Li Z, Sun J, Luo C, Li L, Liu Y, Du Y, Qiu S, Ai X, Wu C, Lian H, He Z. J Control Release; 2015 Jan 10; 197():29-40. PubMed ID: 25449802 [Abstract] [Full Text] [Related]
19. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma. Xin L, Zhang HT, Yang WF, Li YF, Liu C. Biosci Rep; 2018 Feb 28; 38(1):. PubMed ID: 29229675 [Abstract] [Full Text] [Related]
20. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice. Liang Q, Xiang H, Li X, Luo C, Ma X, Zhao W, Chen J, Tian Z, Li X, Song X. Int J Nanomedicine; 2020 Feb 28; 15():7491-7507. PubMed ID: 33116484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]